Sign in

Júlia Pascual

@juliapascual.bsky.social
73 followers 77 following 3 posts

Cardiologist 🩺 / Cardiological Critical Care Unit 🏥 ECMO Team 🫀 #cccsky #cardiosky Menorquina ⛵️

PostsRepliesMedia
Júlia Pascual @juliapascual.bsky.social · 14/11/2025
Mastering the practical application of vasopressin at the bedside in septic shock > It’s worth reading! — clinical pharmacology, dosing, timing...! 📍 rdcu.be/ePAno
link.springer.com
Mastering the practical application of vasopressin at the bedside in septic shock
000
Júlia Pascual @juliapascual.bsky.social · 16/02/2025
Great team work with an excelent result! #cardiosky #cccsky academic.oup.com/ehjcr/articl...
academic.oup.com
Case report: venoarterial extracorporeal membrane oxygenation supported severe coronary vasospasm with recurrent cardiac arrest
AbstractBackground. Coronary vasospasm is a known cause of transient myocardial ischaemia with non-acute significant occlusive atherosclerotic coronary les
110
Júlia Pascual @juliapascual.bsky.social · 06/12/2024
www.jhltonline.org/article/S105... #JHLT Superb “State of art” on RV tMCS devices for RV / BiV shock. I hope they join bluesky soon Navin Kapur, Manreet Kanwar!
jhltonline.org
Pragmatic approach to temporary mechanical circulatory support in acute right ventricular failure
Acute right ventricular failure (RVF) is prevalent in multiple disease states and is associated with poor clinical outcomes. Right-sided temporary mechanical circulatory support (tMCS) devices are used to unload RV congestion and increase cardiac output in cardiogenic shock (CS) with hemodynamically significant RVF. Several RV-tMCS device platforms are available; however consensus is lacking on patient selection, timing of escalation to RV-tMCS, device management, and device weaning. The purposes of this review are to 1) describe the current state of tMCS device therapies for acute RVF with CS, 2) discuss principles of escalation to RV-tMCS device therapy, 3) examine important aspects of clinical management for patients supported by RV-tMCS devices including volume management, anticoagulation, and positive pressure ventilation, and 4) provide a framework for RV-tMCS weaning.
031